p.120 抽出テキスト

400. Lyon AR, Bossone E, Schneider B, et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2016; 18: 8-27. PMID: 26548803 401. Ghadri JR, Kato K, Cammann VL, et al. Long-Term Prognosis of Patients With Takotsubo Syndrome. J Am Coll Cardiol 2018; 72: 874- 882. PMID: 30115226 402. Elgendy AY, Elgendy IY, Mansoor H, et al. Clinical presentations and outcomes of Takotsubo syndrome in the setting of subarachnoid hemorrhage: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2018; 7: 236-245. PMID: 27852798 403. Akashi YJ, Goldstein DS, Barbaro G, et al. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation 2008; 118: 2754-2762. PMID: 19106400 404. Okura H, Nakada Y, Ishihara S, et al. “Hidden” takotsubo cardiomyopathy in cardiac care unit. J Echocardiogr 2020; 18: 113-116. PMID: 31834614 405. Okura H. Echocardiographic assessment of takotsubo cardiomyopathy: beyond apical ballooning. J Echocardiogr 2016; 14: 13-20. PMID: 26694809 406. Kobayashi Y, Okura H, Kobayashi Y, et al. Left ventricular myocardial function assessed by three-dimensional speckle tracking echocardiography in Takotsubo cardiomyopathy. Echocardiography 2017; 34: 523-529. PMID: 28266731 407. Kato K, Kitahara H, Fujimoto Y, et al. Prevalence and Clinical Features of Focal Takotsubo Cardiomyopathy. Circ J 2016; 80: 1824- 1829. PMID: 27295998 408. Kagiyama N, Okura H, Tamada T, et al. Impact of right ventricular involvement on the prognosis of takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging 2016; 17: 210-216. PMID: 26072914 409. Citro R, Bossone E, Parodi G, et al. “Takotsubo Italian Network” Investigators (see Appendix). Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement. Int J Cardiol 2016; 219: 455-461. PMID: 27387098 410. Elesber AA, Prasad A, Bybee KA, et al. Transient cardiac apical ballooning syndrome: prevalence and clinical implications of right ventricular involvement. J Am Coll Cardiol 2006; 47: 1082-1083. PMID: 16516097 411. Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006; 27: 1523-1529. PMID: 16720686 412. Citro R, Rigo F, D’Andrea A, et al. Tako-Tsubo Italian Network Investigators. Echocardiographic correlates of acute heart failure, cardiogenic shock, and in-hospital mortality in tako-tsubo cardiomyopathy. JACC Cardiovasc Imaging 2014; 7: 119-129. PMID: 24412188 413. Haghi D, Röhm S, Suselbeck T, et al. Incidence and clinical significance of mitral regurgitation in Takotsubo cardiomyopathy. Clin Res Cardiol 2010; 99: 93-98. PMID: 19774331 414. Parodi G, Del Pace S, Salvadori C, et al. Tuscany Registry of Tako-Tsubo Cardiomyopathy. Left ventricular apical ballooning syndrome as a novel cause of acute mitral regurgitation. J Am Coll Cardiol 2007; 50: 647-649. PMID: 17692751 415. Kurisu S, Inoue I, Kawagoe T, et al. Incidence and treatment of left ventricular apical thrombosis in Tako-tsubo cardiomyopathy. Int J Cardiol 2011; 146: e58-e60. PMID: 19193453 416. de Gregorio C, Grimaldi P, Lentini C. Left ventricular thrombus formation and cardioembolic complications in patients with Takotsubo-like syndrome: a systematic review. Int J Cardiol 2008; 131: 18- 24. PMID: 18692258 417. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200. PMID: 27206819 418. Sciarretta S, Palano F, Tocci G, et al. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med 2011; 171: 384-394. PMID: 21059964 419. Lip GY, Skjøth F, Overvad K, et al. Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. Clin Res Cardiol 2015; 104: 1088-1096. PMID: 26111867 420. Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 2009; 119: 3070-3077. PMID: 19506115 421. Tsuji K, Sakata Y, Nochioka K, et al. CHART-2 Investigators. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study. Eur J Heart Fail 2017; 19: 1258-1269. PMID: 28370829 422. Dahlöf B, Devereux RB, Kjeldsen SE, et al. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003. PMID: 11937178 423. Kjeldsen SE, Dahlöf B, Devereux RB, et al. LIFE (Losartan Intervention for Endpoint Reduction) Study Group. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491- 1498. PMID: 12243636 424. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001; 19: 921-930. PMID: 11393676 425. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104: 1385- 1392. PMID: 11560854 426. Muscholl MW, Hense HW, Bröckel U, et al. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 317: 565-570. PMID: 9721112 427. Glen SK, Elliott HL, Curzio JL, et al. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348: 654-657. PMID: 8782756 428. Soma J, Widerøe TE, Dahl K, et al. Left ventricular systolic and diastolic function assessed with two-dimensional and doppler echocardiography in “white coat” hypertension. J Am Coll Cardiol 1996; 28: 190-196. PMID: 8752813 429. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458. PMID: 2936235 430. Hare JL, Brown JK, Marwick TH. Association of myocardial strain with left ventricular geometry and progression of hypertensive heart disease. Am J Cardiol 2008; 102: 87-91. PMID: 18572042 431. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36: 2921-2964. PMID: 26320112 432. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2013; 26: 965- 1012. PMID: 23998693 433. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J 2013; 34: 1186-1197. PMID: 23125278 434. Cosyns B, Plein S, Nihoyanopoulos P, et al. European Association of Cardiovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging 2015; 16: 12-31. PMID: 25248336 435. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007; 115: 2739-2744. PMID: 17502574 436. Tsang TS, Enriquez-Sarano M, Freeman WK, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc 2002; 77: 429-436. PMID: 12004992 437. Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown) 2010; 11: 928- 935. PMID: 20814314 438. Sagristà-Sauleda J, Angel J, Sánchez A, et al. Effusive-constrictive pericarditis. N Engl J Med 2004; 350: 469-475. PMID: 14749455 439. Kearns MJ, Walley KR. Tamponade: Hemodynamic and Echocardiographic Diagnosis. Chest 2018; 153: 1266-1275. PMID: 29137910 440. Armstrong WF, Schilt BF, Helper DJ, et al. Diastolic collapse of the right ventricle with cardiac tamponade: an echocardiographic study. Circulation 1982; 65: 1491-1496. PMID: 7074806 441. Mercé J, Sagristà-Sauleda J, Permanyer-Miralda G, et al. Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. Am Heart J 1999; 138: 759-764. PMID: 10502224